The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a call for information on isotretinoin, a treatment for severe acne, which has been linked with psychiatric and sexual side effects. This information is to be considered as part of an expert review of isotretinoin being conducted by MHRA, with advice from the Commission on [ ]
The post MHRA to review acne treatment isotretinoin and suspected links with psychiatric and sexual side effects appeared first on Health Europa.
Thursday 21 January 2021
healtheuropa - 2 month ago
MHRA to review acne treatment isotretinoin and suspected links with psychiatric and sexual side effects
Latest News
⁞
Sources